Home > Healthcare > Healthcare IT > Healthcare Outsourcing > Infection Control Surveillance Solutions Market
Infection Control Surveillance Solutions Market size surpassed USD 580 million in 2021 and is projected to expand at a CAGR of over 13% between 2022 and 2030. The prevalence of nosocomial infections will spur the global industry growth.
The increasing prevalence of nosocomial infections is among the primary factors supporting the industry expansion during the forecast period. Nosocomial infections or Healthcare-associated infections (HAI) are acquired due to prolonged stay or while undergoing treatment across hospital settings. They usually occur within 48 hours or 30 days post-discharge and may include urinary tract infections, surgical site wound infections, respiratory pneumonia, bacteremia, and gastrointestinal and skin infections, among others.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Infection Control Surveillance Solutions Market Size in 2021: | USD 582.4 Million |
Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 13.4% |
2030 Value Projection: | USD 1,797.7 Million |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 240 |
Tables, Charts & Figures: | 182 |
Segments covered: | Component, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
According to the Center for Disease Control and Prevention estimations under the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the most common and widespread hospital-associated infections. In addition, the rapid growth of the aging population and their susceptibility to such infections are likely to create new growth prospects for the infection control surveillance solutions industry in the forthcoming years.
With respect to the component, the infection control surveillance solutions market is bifurcated into software and services. The software segment held more than USD 370 million in revenue in 2021 and is anticipated to follow a positive growth trajectory between 2022 and 2030. The segmental expansion can be credited to the emergence of several healthcare-associated infections and subsequent growth in demand for infection control software. According to the Office of Disease Prevention and Health Promotion, 1 out of every 25 hospitalized patients at any given time in the United States are affected by a healthcare-associated infection. This software help analyzes and shares real-time data and provides feedback that helps medical teams and staff mitigate and control infections more effectively, which will boost its adoption in the forthcoming years.
Based on end-use, the infection control surveillance solutions market is categorized into hospitals, clinics, ambulatory surgical centers, and specialty centers. The hospital segment accounted for more than 67% of the industry share in 2021 and is poised to register significant progress during the assessment period. The increasing burden of infectious and chronic health disorders has resulted in a growing number of people requiring frequent hospitalizations, leading to a considerable rise in hospital-acquired infections and associated healthcare expenditure. This has boosted the demand for better healthcare infrastructure resulting in the construction of new hospitals and healthcare facilities, strengthening the industry outlook.
The North America infection control surveillance solutions market constituted over 44% of the revenue share in 2021 and is likely to experience further expansion in the foreseeable future. The region has registered a noticeable rise in disposable incomes and a significant improvement in economic growth. In addition, the rising healthcare concerns have significantly pushed the healthcare expenditure across the region. North America houses several industry participants that have been focusing on introducing better and advanced products in the market, creating a pool of opportunities for the regional industry.
Some of the prominent companies constituting the infection control surveillance solutions market competitive landscape include players such as
These firms have been implementing technological breakthroughs and new product development as their key growth strategy.
These advanced innovations help them improve their product offerings while offering them a competitive edge over their rival organizations. For instance, in June 2022, Premier announced the expansion of its PINC AI technology platform for clinical surveillance across long-term care facilities. The platform efficiently documents and records data about several infections and offer features such as automatic alerts, poised to broaden the company’s existing customer base.
The outbreak of the COVID-19 pandemic emerged as a boon for the infection control surveillance solutions industry. The exponential rise in COVID-positive patients and the rapidly growing rate of viral transmission resulted in the overcrowding of healthcare facilities. The increasing number of patients requiring hospitalization and critical care caused a dearth of medical staff and hospital beds, pushing the demand for appropriate infection control surveillance systems. In addition, the increasing severity of cruising and the surging morbidities and mortalities led to the growing awareness about safety, health, and hygiene, spurring the demand for infection control measures, thereby facilitating infection control surveillance systems market growth.
The infection control surveillance solutions market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:
Click here to Buy Section of this Report
By Component
By End-user
The above information is provided for the following regions and countries: